Loading clinical trials...
Loading clinical trials...
A Phase II Study of the Efficacy and Tolerability of the Dose Escalation of Sorafenib in Advanced Renal Cell Cancer
Conditions
Interventions
sorafenib
Locations
1
United States
University of Kansas Medical Center
Kansas City, Kansas, United States
Start Date
June 1, 2008
Primary Completion Date
April 1, 2015
Completion Date
April 1, 2015
Last Updated
June 1, 2017
NCT06391099
NCT06349642
NCT04473781
NCT07227415
NCT07294859
NCT07190638
Lead Sponsor
University of Kansas Medical Center
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions